Before the Bell Scans: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca
PLC, and Raptor Pharma Corp.
Editor Note: For more information about this release, please scroll to bottom.
LONDON, August 14, 2013
LONDON, August 14, 2013 /PRNewswire/ --
On Tuesday, August 13, 2013, the U.S. equity market posted modest gains. The
S&P 500 Index gained 0.28% to 1,694.16, the Dow Jones Industrial Average edged
up 0.20% to 15,451.01, and the NASDAQ Composite Index closed 0.39% higher at
3,684.44. Shares in drug manufacturing companies ended higher, tracking gains
in the broader market. The major movers in the sector included GlaxoSmithKline
PLC (NYSE: GSK), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), AstraZeneca PLC
(NYSE: AZN), and Raptor Pharmaceuticals Corp. (NASDAQ: RPTP). All these
companies are tracked by AAAResearchReports.com. Free technical research on
GSK, KERX, AZN, and RPTP can be downloaded upon sign up at:
GlaxoSmithKline PLC's stock edged higher on Tuesday, reversing some of its
recent losses. The company's shares fluctuated between $51.42 and $52.03
before closing the day 1.38% higher at $52.01. A total of 2.48 million shares
were traded which is above the daily average volume of 1.88 million. The stock
has gained 0.68% in the last three trading sessions, compared to a loss of
0.20% in the S&P 500 during the same period. Moreover, the company's shares
are currently trading near their 52-week high of $54.00, and also above their
50-day and 200-day moving averages. Sign up today to read free research report
on GSK at:
Keryx Biopharmaceuticals Inc.'s stock ended slightly higher on Tuesday,
finishing at $8.97, up 0.34% from its previous closing price. The company's
shares fluctuated between $8.79 and $8.98. A total of 0.89 million shares were
traded which is below the daily average volume of 1.96 million. The company's
shares have gained 10.60% in last one month, outperforming the S&P 500 which
gained 0.83% during the same period. Register to download free technical
analysis on KERX at:
Shares in AstraZeneca PLC extended their gains from the previous trading
session. The company's shares fluctuated between $51.00 and $51.48 before
finishing the day 0.80% higher at $51.41. A total of 1.63 million shares were
traded which is above the daily average volume of 1.55 million. The company's
shares have gained 1.86% in the last three trading sessions and 3.69% in the
last one month. The stock is currently trading near its 52-week high of
$53.45. Moreover, company's shares are trading above their 50-day and 200-day
moving averages. A free report on AZN can be accessed by registering at:
Shares in Raptor Pharmaceuticals Corp. rose sharply on Tuesday, tracking gains
in the broader market. The company's shares closed the day 1.51% higher at
$10.77 after fluctuating between $10.40 and $10.80. A total of 0.41 million
shares were traded which is above the daily average volume of 0.35 million. In
the last three months, the stock has gained 82.85%, outperforming the S&P 500
which gained 3.70% during the same period. Additionally, the stock is trading
above its 50-day and 200-day moving averages. Register with AAA Research
Reports and download the research on RPTP for free at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by a CFA ® charterholder. However, we are only human
and are prone to make mistakes. If you notice any errors or omissions,
please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
SOURCE AAA Research Reports
Press spacebar to pause and continue. Press esc to stop.